Cancer Therapies and Cardiomyocyte Viability: Which Drugs are Directly Cardiotoxic?

- Balachandran, Lohis, Haw, Tatt Jhong, Leong, Angeline Jia Wen, Croft, Amanda J., Chen, Dongqing, Kelly, Conagh, Sverdlov, Aaron L., Ngo, Doan T. M.

Elevated Soluble Suppressor of Tumorigenicity 2 Predict Hospital Admissions Due to Major Adverse Cardiovascular Events (MACE)

- Chen, Dongqing, Untaru, Rossana, Stavropoulou, Glykeria, Assadi-Khansari, Bahador, Kelly, Conagh, Croft, Amanda J., Sugito, Stuart, Collins, Nicholas J., Sverdlov, Aaron L., Ngo, Doan T. M.

Heart Failure in Breast Cancer Survivors: Focus on Early Detection and Novel Biomarkers

- Chen, Dongqing, Kelly, Conagh, Haw, Tatt Jhong, Lombard, Janine M., Nordman, Ina I. C., Croft, Amanda J., Ngo, Doan T. M., Sverdlov, Aaron L.

Improving cardiovascular outcomes for cancer patients and survivors: focus on novel biomarkers for risk stratification

- Kelly, Conagh

Overexpression of Mitochondrial Catalase within Adipose Tissue Does Not Confer Systemic Metabolic Protection against Diet-Induced Obesity

- Croft, Amanda J., Kelly, Conagh, Chen, Dongqing, Haw, Tatt Jhong, Sverdlov, Aaron L., Ngo, Doan T. M.

Sex-based differences in short- and longer-term diet-induced metabolic heart disease

- Croft, Amanda J., Kelly, Conagh, Chen, Dongqing, Haw, Tatt Jhong, Murtha, Lucy A., Balachandran, Lohis, Boyle, Andrew J., Sverdlov, Aaron L., Ngo, Doan T. M.

Suboptimal Use of Cardioprotective Medications in Patients With a History of Cancer

- Untaru, Rossana, Chen, Dongqing, Ngo, Doan T. M., Kelly, Conagh, May, Austin, Collins, Nicholas J., Leitch, James, Attia, John R., Proeitto, Anthony M., Boyle, Andrew J., Sverdlov, Aaron L.